Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 2ydo | ADN | Adenosine receptor A2a |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 2ydo | ADN | Adenosine receptor A2a | / | 1.000 | |
| 2ydv | NEC | Adenosine receptor A2a | / | 0.655 | |
| 4uhr | NGI | Adenosine receptor A2a | / | 0.600 | |
| 4ug2 | NGI | Adenosine receptor A2a | / | 0.572 | |
| 5uvi | ZMA | Adenosine receptor A2a | / | 0.559 | |
| 5k2d | ZMA | Adenosine receptor A2a | / | 0.556 | |
| 5k2b | ZMA | Adenosine receptor A2a | / | 0.552 | |
| 5k2c | ZMA | Adenosine receptor A2a | / | 0.549 | |
| 5iub | CLR | Adenosine receptor A2a | / | 0.545 | |
| 5iu8 | 6DZ | Adenosine receptor A2a | / | 0.544 | |
| 5iua | 6DX | Adenosine receptor A2a | / | 0.536 | |
| 5iu4 | ZMA | Adenosine receptor A2a | / | 0.529 | |
| 5jtb | ZMA | Adenosine receptor A2a | / | 0.529 | |
| 5k2a | ZMA | Adenosine receptor A2a | / | 0.525 | |
| 5g53 | NEC | Adenosine receptor A2a | / | 0.519 | |
| 3eml | ZMA | Adenosine receptor A2a | / | 0.506 | |
| 4eiy | ZMA | Adenosine receptor A2a | / | 0.490 | |
| 2j3j | HC4 | NADPH-dependent oxidoreductase 2-alkenal reductase | 1.3.1.74 | 0.471 | |
| 2qd4 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.468 | |
| 3slk | NDP | Polyketide synthase extender module 2 | / | 0.466 | |
| 3gmd | 2M3 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.463 | |
| 2i9p | NAD | 3-hydroxyisobutyrate dehydrogenase, mitochondrial | 1.1.1.31 | 0.462 | |
| 3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.459 | |
| 3qak | UKA | Adenosine receptor A2a | / | 0.458 | |
| 4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.457 | |
| 4q73 | FAD | Bifunctional protein PutA | / | 0.455 | |
| 1osv | CHC | Bile acid receptor | / | 0.454 | |
| 1l2j | ETC | Estrogen receptor beta | / | 0.453 | |
| 2qd5 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.453 | |
| 4ib4 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.451 | |
| 2j3i | NAP | NADPH-dependent oxidoreductase 2-alkenal reductase | 1.3.1.74 | 0.450 | |
| 4l0q | NAD | Alcohol dehydrogenase class-3 | / | 0.450 | |
| 3vg9 | ZMA | Adenosine receptor A2a | / | 0.448 | |
| 4wo5 | 324 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.448 | |
| 2w98 | P1Z | Prostaglandin reductase 2 | 1.3.1.48 | 0.447 | |
| 4dqu | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.447 | |
| 4jv8 | 1M1 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.447 | |
| 2aib | ERG | Beta-elicitin cinnamomin | / | 0.446 | |
| 4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.446 | |
| 3uzc | T4E | Adenosine receptor A2a | / | 0.446 | |
| 1y5r | C0R | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.445 | |
| 2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.445 | |
| 3is9 | AC7 | Gag-Pol polyprotein | 2.7.7.49 | 0.444 | |
| 3uza | T4G | Adenosine receptor A2a | / | 0.444 | |
| 2j9l | ATP | H(+)/Cl(-) exchange transporter 5 | / | 0.443 | |
| 2pl0 | STI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.443 | |
| 3w1w | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.443 | |
| 3ctj | 320 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.442 | |
| 3nx4 | NAP | Putative oxidoreductase | / | 0.441 | |
| 3ule | C69 | Actin-related protein 3 | / | 0.440 | |
| 5dp2 | NAP | CurF | / | 0.440 |